Urgent action is needed to encourage the US Department of Education to release updated rules on Section 504 of the Rehabilitation Act of 1973, which provides educational accommodations for children who have ADHD. The process for this release has currently slowed due to a complication at the US Department of Justice, and time is running…

ADHD Medication Shortages: What to Know and Do By Andrew Adesman, MD, and Anna Krevskaya, MD Attention, October 2023 In recent years, many new stimulant medications have been approved by the US Food and Drug Administration (FDA) for treatment of ADHD. These new formulations vary in their duration of benefit, and many offer new ways…

We have heard the frustrations many members of the ADHD community are experiencing when they go to refill their ADHD medications, the disappointment and worry when the pharmacy is unable to fill a prescription because of the ongoing shortage. CHADD’s public policy committee is pursuing all appropriate channels to bring this to the attention of…

The challenges today’s generation of young people face are unprecedented and uniquely hard to navigate. And the effect these challenges have had on their mental health is devastating. Recent national surveys of young people have shown alarming increases in the prevalence of certain mental health challenges. We know that mental health is shaped by many…

Posted October 8, 2020 Presentation to the Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of the US Food and Drug Administration Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder Presented by Robert Cattoi, CHADD Chief Executive Officer Children and Adults with Attention-Deficit/Hyperactivity Disorder…

CHADD is pleased to report that Secretary of Education Betsy DeVos will not seek changes to the central tenets of the Individuals with Disabilities Education Act (IDEA) in response to the novel coronavirus pandemic. In her report, the Secretary is “not requesting waiver authority for any of the core tenets of the IDEA or Section…

Read the update to this post. Dear Parents, The Coronavirus Aid, Relief, and Economic Security (CARES) Act, PL 116-136, directs Secretary of Education Betsy DeVos to report back to Congress no later than April 26, 2020, on any waivers needed under the Individuals with Disabilities Education Act (IDEA) and the Rehabilitation Act of 1973 (Section…

The CHADD Public Policy Committee is sharing the document Questions and Answers on Providing Services to Children with Disabilities during the Coronavirus Disease 2019 Outbreak. This document addresses questions on IDEA and Section 504 educational plans, along with meeting the needs of children with disabilities who may also be affected by COVID-19. The Centers for…

The US Food and Drug Administration recently asked for comments on making stimulant medications more difficult to abuse and how those changes could affect the millions of people who include medication in their ADHD treatment plans. The Federal Register notice states that stimulant medications can be open to abuse but that reformulating them can potentially…

At eight years old, Michael was diagnosed with ADHD. The traditional city school he attended declined to evaluate him to determine eligibility for special education and related services because his grades were above average. Instead, the school provided Michael with minimal accommodations through a 504 plan. As the years progressed, Michael’s grades began to decline,…

CHADD and Russell A. Barkley, Ph.D., Partner Announce New Findings   Lanham, Md. (Jan. 8, 2019)— The message is clear. Treatment for attention-deficit/hyperactivity disorder (ADHD), along with the related health risks it poses, has the possibility of adding an average of nine to 13 years to the lifespan of children and adults diagnosed with ADHD.…